companydata.dkcompanydata.dk

AVP BioPharma Consult ApS: Financial statements 2019

CVR: 37770426

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

AVP BioPharma Consult ApS (CVR 37770426) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,462,906 and a net result of DKK 319,722 compared with DKK 71,232 the year before. That is an increase of 45.6% compared with the year before. Equity in the 2019 report amounted to DKK 375,210. The solvency ratio was 78.2%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,462,906
Profit/Loss
DKK 319,722
Equity
DKK 375,210
Total Assets
DKK 479,627
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-1.5M320K375K1
2018-1M71K126K1
2017-1.1M58K142K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

AVP BioPharma Consult ApS: The 2018 annual report is outMar 11, 2019

AVP BioPharma Consult ApS has published its annual report for 2018. Gross profit came to DKK 1,004,674, and the net result was DKK 71,232.

About AVP BioPharma Consult ApS

AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.

Source: annual report 2025, Danish Business Authority